MedTrace Logo

Characterization of the Neural Bases of Mental Imagery in Individuals With Borderline Personality Disorder: An EEG Study

NCT07428200 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2026-02-23

No results posted yet for this study

Summary

Borderline Personality Disorder (BPD) involves altered social cognition, notably dysfunctional processing of cues signaling potential social exclusion and heightened social pain. This study uses EEG during a controlled Cyberball task to test whether BPD patients show a functionally altered social-pain network, particularly increased theta activity, when experiencing induced social exclusion.

Conditions

  • Borderline Personality Disorder BPD

Interventions

BEHAVIORAL

2 Tasks : - stop signal reaction time and Cyberball then ill out an evaluation form

Upon arrival, during electrode placement, participants will complete a stop-signal reaction time (SSRT) task measuring cognitive control for approximately ten minutes. Following this, they will participate in an online ball game, Cyberball, a controlled laboratory task simulating social inclusion or exclusion. The Cyberball task will last approximately 20 minutes and will consist of three experimental conditions presented in a fixed order: passive viewing, inclusion, and then exclusion. During this time, participants' visual activity will be measured using eye tracking. At the end of the Cyberball game, participants will complete: * Social Ostracism and Cohesion Rating Scales * Need Threat Scale

Sponsors & Collaborators

  • Hôpital le Vinatier

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2026-03-01
Completion
2029-03-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07428200 on ClinicalTrials.gov